Physician profile
Neeraj Tandon
NPI 1710904628
$5,392.30
in general payments reported to CMS, 2019-2025
9 companies · $42.57 in 2025
The $42.57 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.45 · 2020: $970 · 2022: $4,203 · 2023: $131 · 2024: $14.72 · 2025: $42.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,472.68 | 2022 | |
| Medtronic, INC. | $1,837.54 | 2022-2023 | Onyx Frontier |
| Philips North America LLC | $696.06 | 2020 | |
| Boston Scientific Corporation | $289.03 | 2020-2024 | Ranger |
| Abiomed | $42.57 | 2025 | |
| Medtronic Vascular, INC. | $30.45 | 2019 | |
| Amgen INC. | $23.97 | 2023 | Repatha |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeraj Tandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.